U.S. Transportation Stock News

If you are wondering whether Ferguson Enterprises at around US$246.53 is still worth your attention, it helps to start by separating price moves from underlying value. The stock has seen a 7.9% decline over the last 7 days, set against returns of 4.5% over 30 days, 9.6% year to date, 46.3% over 1 year, 78.6% over 3 years and 109.5% over 5 years. This naturally raises questions about how much future strength or risk is already reflected in the price. Recent coverage of Ferguson Enterprises...

MNTN, Inc. recently reported first-quarter 2026 results, with sales rising to US$73.67 million and net income improving to US$8.76 million, reversing a net loss a year earlier and lifting basic earnings per share from continuing operations to US$0.12. On the same day, the company launched QuickFrame AI 3.0, expanding its AI-powered creative platform into a full production workflow that lets brands rapidly generate, edit, and publish multi-format video ads across major digital and TV...

Insmed (INSM) opened Q1 2026 with revenue of US$306 million and a basic EPS loss of US$0.76, while the trailing twelve months show revenue of US$820 million and a basic EPS loss of US$5.70. Over the past reported quarters, revenue has moved from US$93 million in Q1 2025 to US$306 million in Q1 2026, alongside quarterly basic EPS losses ranging between US$0.76 and US$1.75. This keeps the focus squarely on how efficiently new sales translate into narrowing losses. For investors, the story this...

Affirm Holdings (AFRM) opened its Q2 2026 update with total revenue of US$1.1b and basic EPS of US$0.39, alongside trailing twelve month revenue of US$3.7b and EPS of US$0.86 that put profitability firmly in focus. The company has seen quarterly revenue move from US$866.4m in Q2 2025 to US$1.1b in Q2 2026, while basic EPS shifted from US$0.25 to US$0.39 over the same period. This sets up this print as a key checkpoint on whether margins are starting to scale more consistently. See our full...

Curious whether Luckin Coffee at US$33.44 is giving you real value or just headline noise? This article breaks down what the current price might be implying about the stock. The stock has been choppy recently, with a 4.5% decline over the last week, a 2.9% gain over the last 30 days, a 5.6% year to date decline, and a 2.9% return over the last year, on top of a 65.2% return over three years and a very large gain over five years. Recent coverage of Luckin Coffee has focused on its position in...

Wondering whether Intuitive Machines stock still offers value after its recent volatility, or if you might be turning up late to the story? The stock closed at US$24.11, with a 4.9% decline over the last 7 days, a 6.1% gain over 30 days, a 34.8% return year to date, and a 157.9% return over the past year. Recent headlines around Intuitive Machines have kept the stock in focus, with investors paying closer attention to how its projects translate into long term potential. This context helps...

eXp World Holdings (AGNT) recently drew attention after eXp Commercial added veteran broker Mario J Alvarez Jr, whose two decades in commercial real estate align with the company’s effort to grow its investment sales presence. See our latest analysis for eXp World Holdings. At a share price of $6.60, eXp World Holdings has a 30 day share price return of 10.18% and a 7 day gain of 2.48%. However, the year to date share price return of 27.47% and 90 day share price return of 23.79% point to...

In April 2026, SS&C Technologies Holdings launched SS&C Blue Prism WorkHQ, an agentic automation platform that unifies people, AI agents, APIs, and digital workers under a single, governed control plane to help enterprises run AI-enabled workflows with embedded security, auditability, and compliance. Built on SS&C’s own large-scale use of more than 4,000 digital workers and over 50 AI agents, WorkHQ aims to help customers shift from isolated AI pilots to governed, enterprise-wide automation...

Wondering whether Taiwan Semiconductor Manufacturing stock still offers value after its strong run, or if you might be arriving late to the story? The share price last closed at US$414.15, with returns of 4.6% over 7 days, 19.9% over 30 days, 29.6% year to date, 138.6% over 1 year, 413.9% over 3 years and 306.3% over 5 years. Recent headlines have focused on Taiwan Semiconductor Manufacturing's central role in global chip supply and its position in advanced manufacturing capacity. This...

If you are wondering whether Grindr stock is priced fairly or if the current level still leaves room for value, you need to look past headlines and into the numbers that shape valuation. Over the last month the share price has moved to US$13.81, with returns of 3.3% over 7 days, 12.4% over 30 days and 3.8% year to date, set against a 43.5% loss over the past year and a 124.2% gain over three years. Recent coverage has focused on Grindr as a listed platform business and how investors are...

If you are wondering whether Apollo Global Management's current share price lines up with its underlying worth, this article walks through the key numbers in plain language. The stock last closed at US$127.79, with a 21.3% gain over the past 30 days, a 0.7% decline over 7 days, a 12.8% decline year to date and a 2.6% decline over the past year. This is set against a 110.8% return over 3 years and a 152.8% return over 5 years. Recent attention on Apollo Global Management has focused on how...

Masimo shareholders have officially approved the merger with Danaher (NYSE:DHR). The vote clears a key milestone for the acquisition and allows the deal process to move toward closing. The transaction is expected to expand Danaher's presence in diagnostics and medical technology once remaining conditions are met. For investors watching NYSE:DHR, this approval matters because it comes at a time when diagnostics, patient monitoring and broader medical technology are central to hospital and...

If you are trying to figure out whether Apellis Pharmaceuticals is attractively priced today, it helps to start with how the current market value lines up against different ways of estimating fair value. The stock last closed at US$41.01, with returns of 0.1% over 7 days, 0.8% over 30 days, 58.6% year to date and 130.3% over the past year, alongside 3 year and 5 year returns of 53.7% decline and 10.1% decline respectively. This gives a mixed picture for anyone thinking about entry or exit...

Vistra (VST) has wrapped up FY 2025 with fourth quarter revenue of US$4.6b, Basic EPS of US$0.55 and net income of US$185m, rounding out a trailing twelve month picture that totals US$17.7b in revenue, Basic EPS of US$2.22 and net income of US$752m. Over recent quarters, reported revenue has moved from US$4.0b in Q4 2024 to US$4.6b in Q4 2025, while quarterly Basic EPS has ranged from US$1.16 in Q4 2024 to US$0.55 most recently, setting up a results season where investors are weighing...

Earlier this week, enGene Therapeutics reported interim Phase 2 LEGEND trial results for its bladder cancer gene therapy detalimogene voraplasmid, revealing a 54% complete response rate but weaker 12‑month durability than previously expected, alongside generally manageable side effects and low disease progression. The mixed efficacy profile has triggered analyst downgrades and shareholder-rights investigations, highlighting how a single data update can rapidly reshape perceptions of a...

If you are wondering whether Planet Labs PBC at around US$35.24 is priced attractively or already baking in big expectations, it helps to step back and look at how the stock has been behaving and what that might imply about value. The share price is around US$35.24, with a 4.7% decline over the last week, roughly flat at 0.2% over the past month, a 72.7% gain year to date, and a very large rise over the past year that is close to 9x, as well as very strong multi year returns. These moves...

NiSource (NYSE:NI) announced new and expanded partnerships with Amazon and Alphabet that are expected to support $1.4 billion in customer savings over 15 years. Alongside these partnerships, the company updated its long term adjusted EPS growth outlook to a range of 9% to 10% through 2033. For investors watching utilities, NiSource stands out with a current share price of $47.02 and a 5 year return of 115.2%. The stock has also returned 21.9% over the past year and 83.7% over 3 years,...

Geopolitical tensions and higher oil prices are pushing up ocean freight costs for Columbia Sportswear, raising questions about future gross margins. Renewed U.S. Iran frictions are contributing to more expensive international shipping, which could affect sourcing and distribution for Columbia's global business. These supply chain pressures come as investors focus on how apparel companies handle external cost shocks alongside consumer demand trends. Columbia Sportswear (NasdaqGS:COLM) is...

eToro Group (NasdaqGS:ETOR) CEO Yoni Assia has outlined a vision for capital markets built around 24/7 crypto trading and always-on access. In recent interviews, Assia described a future where autonomous, AI-driven agents participate in markets continuously across assets and platforms. The comments highlight eToro’s focus on AI-managed investment strategies and a machine-led trading framework that does not rely on traditional market hours. eToro runs a multi asset trading and investment...

In the first quarter of 2026, Medical Properties Trust reported revenue of US$252.07 million and net income of US$32.83 million, reversing a prior-year net loss and lifting earnings per share from a loss of US$0.20 to a profit of US$0.05. This shift from loss to profit, alongside higher sales versus a year earlier, suggests management’s efforts to stabilize operations and rental income are beginning to show up in the company’s financial results. With Medical Properties Trust returning to...

This article examines whether Primo Brands, trading at around US$22.24, currently represents value or risk by exploring what the share price might be implying. The stock has returned 9.1% over the last 7 days, 21.3% over the last 30 days and 37.4% year to date, while the 1 year return reflects a 29.8% decline and the 3 and 5 year returns are 69.8% and 48.4% respectively. Recent market interest in Primo Brands appears tied to broader investor attention on beverage companies listed in the US...

Booz Allen Hamilton (NYSE:BAH) has appointed former U.S. Army Chief Information Officer Leonel Garciga as Senior Executive Advisor. Garciga is expected to focus on artificial intelligence and defense technology initiatives across the firm’s government-focused business. The appointment centers on AI integration and large-scale technology transformation for defense clients. Booz Allen Hamilton, through its consulting and technology services, is deeply tied to U.S. federal defense and...

Pitney Bowes (NYSE:PBI) received Impact Level 4 (IL4) Provisional Authorization for its SendPro 360 cloud platform. The IL4 approval permits use of SendPro 360 by the U.S. Department of Defense and authorized contractors. This accreditation expands access to secure federal technology workloads and supports the company’s government-focused offerings. Pitney Bowes, known for mailing, shipping, and related software, now has SendPro 360 cleared for higher security federal use through the IL4...

Why Disc Medicine’s latest trial milestones matter for investors Disc Medicine (IRON) has moved its pipeline forward by completing enrollment in the pivotal Phase 3 APOLLO trial of bitopertin in erythropoietic protoporphyria, while also preparing new data readouts across other hematology programs. See our latest analysis for Disc Medicine. The latest trial milestones arrive after a mixed stretch in the market, with the share price at US$67.53 showing a 1-year total shareholder return of...